Developing a New Class of Engineered Live Bacterial Therapeutics to Treat Human Diseases
Nature Communications - United Kingdom
doi 10.1038/s41467-020-15508-1
Full Text
Open PDFAbstract
Available in full text
Date
April 8, 2020
Authors
Publisher
Springer Science and Business Media LLC